Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Plos One|July 31, 2018
Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expressionDominik Summer, Andrea Kroess, Rudolf Woerndle, et al.Contrast Media & Molecular Imaging|June 1, 2018
Exploiting the Concept of Multivalency with <sup>68</sup>Ga- and <sup>89</sup>Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R ExpressionDominik Summer, Christine Rangger, Maximilian Klingler, et al.Molecular Imaging and Biology|March 7, 2019
Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal InfectionPiriya Kaeopookum, Dominik Summer, Joachim Pfister, et al.Molecular Pharmaceutics|February 14, 2017
Sulfonation of Tyrosine as a Method To Improve Biodistribution of Peptide-Based Radiotracers: Novel <sup>18</sup>F-Labeled Cyclic RGD AnaloguesMohammad B Haskali, Delphine Denoyer, Wayne Noonan, et al.Bioconjugate Chemistry|May 3, 2017
Developing Targeted Hybrid Imaging Probes by Chelator ScaffoldingDominik Summer, Leo Grossrubatscher, Milos Petrik, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2011
[68Ga]NODAGA-RGD for imaging αvβ3 integrin expressionPeter A Knetsch, Milos Petrik, Christoph M Griessinger, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2011
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607Meltem Ocak, Anna Helbok, Christine Rangger, et al.Pharmaceuticals (Basel, Switzerland)|December 31, 2020
Selection of the First <sup>99m</sup>Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized CandidatesMelpomeni Fani, Viktoria Weingaertner, Petra Kolenc Peitl, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 31, 2016
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trialDariusz Pawlak, Christine Rangger, Petra Kolenc Peitl, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
Safety, Biodistribution, and Radiation Dosimetry of the <sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine TumorsElisabeth von Guggenberg, Gianpaolo di Santo, Christian Uprimny, et al.Pageof 6